Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150. - Thambi, Nithya; Phuah, Jia Yao; Staupe, Ryan P; Tobias, Lori M; Cao, Yu; McKelvey, Troy; Railkar, Radha A; Aliprantis, Antonios O; Arriola, Carmen Sofia; Maas, Brian M; Vora, Kalpit A (Journal of Infectious Diseases, 2025)